LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED

Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New pill targets genetic driver in advanced cancers

Disease control Not yet recruiting

This early-stage study is testing a new oral drug, GenSci145, in people with advanced solid tumors that have a specific genetic change called a PIK3CA mutation. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that…

Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED

Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED

Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS WITH PIK3CA-MUTATED trials appear

New pill targets genetic driver in advanced cancers